plafibride has been researched along with Hyperlipoproteinemia Type II in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gómez, JM; Morató, J; Soler, J; Vinzia, C | 1 |
| Jover, E; López, IM; Rodriguez, F | 1 |
2 other study(ies) available for plafibride and Hyperlipoproteinemia Type II
| Article | Year |
|---|---|
[Plafibride treatment of hyperlipidemias type II and IV].
Topics: Adult; Cholesterol; Clofibrate; Clofibric Acid; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Hypolipidemic Agents; Male; Middle Aged; Triglycerides | 1984 |
Plafibride treatment and serum lipids in hyperlipoproteinemias.
Topics: Adolescent; Adult; Blood Glucose; Cholesterol; Clofibrate; Clofibric Acid; Diet; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Insulin; Male; Phosphatidylcholines; Triglycerides | 1987 |